Delivery Order SPE2DB24D2018-SPE2DB26FWRP2
- Not listed
- The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tavalisse 100 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $18,533.40 and an ultimate completion date of August 12, 2025. The award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. Tavalisse is a pharmaceutical product used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for Tavalisse 150 mg tablets (60-count) on September 3, 2025, with completion expected by September 24, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tavalisse is a prescription medication used to treat immune thrombocytopenia, a bleeding disorder affecting...
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Tavalisse 100 mg tablets (60-count units). This is a non-set-aside contract with a completion date of July 31, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a contract ceiling value of $9,266.70. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $9,266.70. This firm fixed-price delivery order, due for completion by September 23, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $18,533.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the awardee's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,266.70 to AmerisourceBergen Drug Corp for the supply of Tavalisse 100 mg tablets (60 count) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of October 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance of the work taking place at its corporate office location...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB26FWRP2Delivery Order
The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 60 tablets of Tavalisse 100 mg, a pharmaceutical product for immune thrombocytopenia treatment. The contract, which is a child order under a larger indefinite delivery vehicle, requires completion by November 19, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical procurement standards. This award is issued as a delivery order under AmerisourceBergen's $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The prime contract enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency and other federal healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical product deliveries across multiple therapeutic domains, demonstrating significant scale and capability within the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 10/28/25 |